C Difficile Vaccine Provides Preventative Potential
November 09, 2018
Catia Mato Ferreira, PhD, global medical lead of Medical Affairs at Pfizer discussed the preventive potential of the C difficile vaccine that is currently in development in a phase 3 trial.